Related Experiment Video
Updated: Sep 26, 2025

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
Published on: May 5, 2022
COVID-19-Associated Myocarditis: An Evolving Concern in Cardiology and Beyond
Meg Fraser1, Arianne Clare C Agdamag1, Valmiki R Maharaj1
1Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, MN 55455, USA.
Insights
Coronavirus disease 2019 (COVID-19) infection is linked to myocarditis, an inflammation of the heart muscle. While the overall incidence is low, infected individuals face increased risks, necessitating ongoing research into diagnosis and treatment.
Area of Science:
- Cardiology
- Infectious Diseases
- Immunology
Background:
- Direct and indirect adverse effects of SARS-CoV-2 infection on the cardiovascular system are critical, impacting disease course, clinical outcomes, and recovery.
- Myocarditis, an inflammation of the heart muscle, is a significant concern associated with SARS-CoV-2 infection.
- Rapidly evolving knowledge necessitates continuous updates for the scientific and medical community regarding COVID-19-associated cardiovascular complications.
Purpose of the Study:
- To provide an updated review on the incidence of Coronavirus disease 2019 (COVID-19)-associated myocarditis.
- To summarize recent data on the pathophysiology and diagnostic evaluation of COVID-19-associated myocarditis.
- To include an update on proposed mechanisms of myocarditis in COVID-19 vaccine recipients.
Main Methods:
- Literature review and synthesis of recent data.
- Analysis of incidence rates and risk factors for COVID-19-associated myocarditis.
- Review of diagnostic tools, including serum biomarkers and imaging modalities.
- Examination of proposed mechanisms for vaccine-induced myocarditis.
Main Results:
- Recent data indicate a relatively low overall incidence of SARS-CoV-2-associated myocarditis.
- Individuals infected with SARS-CoV-2 exhibit a substantially increased risk of developing myocarditis.
- Understanding pathophysiology and diagnostic evaluation remains crucial for managing COVID-19-associated myocarditis.
Conclusions:
- COVID-19-associated myocarditis, though not highly frequent, poses a significant risk to infected individuals.
- Continued research into diagnostic strategies and pathophysiological mechanisms is essential.
- Emerging data on vaccine-associated myocarditis warrant attention and further investigation.
Abstract:
The direct and indirect adverse effects of SARS-CoV-2 infection on the cardiovascular system, including myocarditis, are of paramount importance. These not only affect the disease course but also determine clinical outcomes and recovery. In this review, the authors aimed at providing an update on the incidence of Coronavirus disease-2019 (COVID-19)-associated myocarditis. Our knowledge and experience relevant to this area continues to evolve rapidly since the beginning of the pandemic. It is crucial for the scientific and medical community to stay abreast of current information. Contrasting early reports, recent data suggest that the overall incidence of SARS-CoV-2-associated myocarditis is relatively low, yet infected individuals are at a substantially increased risk. Therefore, understanding the pathophysiology and diagnostic evaluation, including the use of serum biomarkers and imaging modalities, remain important. This review aims to summarize the most recent data in these areas as they relate to COVID-19-associated myocarditis. Given its increasing relevance, a brief update is included on the proposed mechanisms of myocarditis in COVID-19 vaccine recipients.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy